Mainz Biomed B.V.
$3.59▲ 0.84%(+$0.03)
TickerSpark Score
58/100
▌ Mixed
40
Valuation
40
Profitability
55
Growth
76
Health
80
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYNZ research report →
52-Week Range63% of range
Low
$0.55
Current
$3.59
High
$5.34
Company Overviewmainzbiomed.com
About the company
Mainz Biomed B. V. is a German company specializing in molecular genetics for the development of cancer diagnostics.
- CEO
- Guido Baechler
- IPO
- 2021
- Employees
- 19
- HQ
- Mainz, DE
Price Chart
-14.56% · this period
Valuation
- Market Cap
- $14.69M
- P/E
- -3.37
- P/S
- 63.29
- P/B
- 3.73
- EV/EBITDA
- -1.85
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -2723.55%
- Net Margin
- -2937.85%
- ROE
- -325.93%
- ROIC
- -165.58%
Growth & Income
- Revenue
- $537.08K · -39.92%
- Net Income
- $-16,210,718 · 25.13%
- EPS
- $-2.70 · 87.92%
- Op Income
- $-13,498,818
- FCF YoY
- 36.69%
Performance & Tape
- 52W High
- $5.34
- 52W Low
- $0.55
- 50D MA
- $0.97
- 200D MA
- $1.38
- Beta
- 0.32
- Avg Volume
- 554.37K
Get TickerSpark's AI analysis on MYNZ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 8, 26 | Ben-Tzvi Avraham | other | 137,141 |
| May 8, 26 | NATAN DAVID | other | 137,141 |
| Apr 22, 26 | Lazar David E. | other | 1,000,000 |
| Apr 22, 26 | Lazar David E. | other | 1,000,000 |
| Feb 13, 26 | Lazar David E. | other | 1,000,000 |
| Feb 13, 26 | Lazar David E. | other | 1,000,000 |
| Feb 13, 26 | Lazar David E. | other | 1,000,000 |
| Feb 13, 26 | Lazar David E. | other | 0 |
| Feb 13, 26 | Caragol William J | other | 290,000 |
| Feb 13, 26 | Dreismann Heinrich | other | 45,000 |
Coverage · MYNZ
Our MYNZ coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on MYNZ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MYNZ report →Internal Compare
Similar companies
Peers in the same neighborhood.